Investors
Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism.
Nasdaq: AGIO
    
Event Details

Agios Pharmaceuticals Inc at 35th Annual J.P. Morgan Healthcare Conference

Monday, January 9, 2017 10:00 a.m. PT  
Title
Agios Pharmaceuticals Inc at 35th Annual J.P. Morgan Healthcare Conference
Date / Time
01/09/17 10:00 a.m. PT